Ya‐Wen Yang

机构：Johnson & Johnson (United States), China University of Geosciences, Jilin Province Tumor Hospital, Janssen (United States) · ORCID：0000-0001-6330-6830

发表论文 73 篇 · 总被引 1189 次 · h-index 19

代表论文

• Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis (2023 · Drug Safety · 被引 57)
• Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure (2023 · British Journal of Dermatology · 被引 42)
• Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials (2023 · Journal of the American Academy of Dermatology · 被引 21)
• Trends and sex‐specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study (2023 · Cancer Medicine · 被引 19)
• The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases (2023 · Advances in Therapy · 被引 14)
• Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials (2023 · British Journal of Dermatology · 被引 13)